Home > Company

CORE VALUE

Realize prompt and accurate molecular diagnostics and support early-stage

diagnosis and timely personalized medicine. 

We are developing nucleic acid preparation and MDx and CDx technology targeting various infectious diseases and genetic disorders including COVID-19, mycobacterium tuberculosis,

fungal diseases, Orientia tsutsugamushi and liquid biopsy from cancers. 

EXPERTISE

Focus on developing products that exhibit optimal

performance in the MDx market.

HORIZONTAL

Pursue efficient cooperation in a horizontal company

culture and releasing a wide range of MDx products.

ORIGINALITY

Encourage creative thinking and put our efforts

on developing innovative products.

We are focused on developing innovative technology that could continuously contribute to medical diagnosis even in the circumstances of rapidly changing IVD market.

Our development goal is to realize prompt and accurate MDx even when there are low quantity of pathogens from various diseases.

(주) 인퓨전텍 I 대표자 : 김남헌 I 사업자등록번호 : 492-87-01515

대표전호 : 031)687-3459 I 팩스 : 031)624-1518 I 이메일 : infusion@infusiontech.co.kr I (14059) 경기도 안양시 동안구 흥안대로 427번길 38, 성지스타위드 1202호

INFUSIONTECH, Inc.ㅣ CEO : Nam Heon, Kim ㅣ Company Registration Number : 492-87-01515

 Tel: +82-31-687-3459 ㅣFAX : +82-31-624-1518 ㅣ E-Mail: infusion@infusiontech.co.kr

#1202, 38, Heungan-daero 427 beon-gil, Dongan-gu, Anyang-si, Gyeonggi-do, Korea 

COPYRIGHT INFUSIONTECH © 20‌20. ALL RIGHTS RESERVED.